|
SLC31A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.31229999592131E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6645573808205E-12 |
| Normal-vs-Stage2 |
3.424200E-04 |
| Normal-vs-Stage3 |
1.72370000051103E-07 |
| Normal-vs-Stage4 |
4.576800E-04 |
| Stage1-vs-Stage2 |
5.903800E-02 |
| Stage1-vs-Stage3 |
4.763800E-01 |
| Stage1-vs-Stage4 |
6.946200E-01 |
| Stage2-vs-Stage3 |
2.416400E-01 |
| Stage2-vs-Stage4 |
3.968600E-01 |
| Stage3-vs-Stage4 |
9.528200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.14789999727805E-08 |
| Normal-vs-AfricanAmerican |
3.08970005136189E-09 |
| Normal-vs-Asian |
5.538900E-03 |
| Caucasian-vs-AfricanAmerican |
4.722800E-01 |
| Caucasian-vs-Asian |
9.254600E-01 |
| AfricanAmerican-vs-Asian |
8.870800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.97629998214211E-09 |
| Normal-vs-Female |
9.7534999965454E-08 |
| Male-vs-Female |
1.665640E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.88720000024756E-07 |
| Normal-vs-Extreme_Weight |
1.01469999069792E-09 |
| Normal-vs-Obese |
1.50099999096653E-09 |
| Normal-vs-Extreme_Obese |
1.182970E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.586640E-01 |
| Normal_Weight-vs-Obese |
9.969600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.362400E-01 |
| Extreme_Weight-vs-Obese |
5.497700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.418050E-01 |
| Obese-vs-Extreme_Obese |
7.947200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.42629999991762E-07 |
| Normal-vs-Age(41-60Yrs) |
2.49989999812072E-08 |
| Normal-vs-Age(61-80Yrs) |
1.84841031369842E-12 |
| Normal-vs-Age(81-100Yrs) |
3.15159999986214E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.753400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.867400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.680800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.306400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.898400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.333200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.40360001399387E-09 |
| Normal-VS-Type2 PRCC |
1.80757999999059E-05 |
| Normal-VS-KIRP CIMP |
8.558200E-03 |
| Normal-VS-Unclassified PRCC |
1.18839999951881E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.814140E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.041000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.286000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.404600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.661700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.038000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.4058999964206E-08 |
| Normal-vs-N1 |
2.64920000381252E-08 |
| Normal-vs-N2 |
6.356000E-02 |
| N0-vs-N1 |
7.027000E-01 |
| N0-vs-N2 |
6.317400E-01 |
| N1-vs-N2 |
6.912200E-01 |
|
|
